Boston Life Sciences, Inc.
Medical device firm takes steps to further its focus on neurology
Published in Mental Health Business Week, September 3rd, 2005
FluoroPharma is an emerging diagnostic discovery company with proprietary PET technology focused primarily on the diagnosis of cardiovascular disease. In 2004, FluoroPharma agreed to grant BLSI a right of participation in the event that FluoroPharma pursued a development and/or sublicensing agreement for its imaging agents with an established biotechnology or pharmaceutical company.
BLSI is primarily focused on developing products for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- National MS Society
$30 million "Promise 2010" initiative launched to propel MS research and care - Neurocrine Biosciences, Inc.
Biopharmaceutical company reports second quarter 2005 results - Neurogen Corporation
Drug discovery company announces second quarter 2005 financial results - Northwest Biotherapeutics, Inc.
Biotechnology company announces appointment of medical director - Psychiatric Solutions, Inc.
Behavioral health company announces financial results - ASITN
Endovascular therapy may greatly benefit severe aneurysm patients, study shows - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
